Med-X innovates all-natural and alternative solutions to everyday problems. Currently, Med-X products provide effective nontoxic and 100% all-natural pest management products to cannabis cultivators. These same products are currently used widely in the pest control and hospitality arenas nationally.
The Marijuana Times, the media division of Med-X, publishes original content aimed at educating the cannabis community on the medicine, the science, and the world of the cannabis industry. With an all-star management team and experienced doctors at the helm, Med-X is blazing the trail of the green scene with products aimed at helping people to live better lives.
Inform the public through a digital magazine.
Through The Marijuana Times digital magazine, Med-X aims to educate and provide thoughtful and engaging articles and facts about and for the cannabis community.
Introduce all-natural products for cultivation
Med-X innovates, researches, and develops a variety of natural products that provide safe alternatives to consumers. One Med-X exclusively licensed product "Nature-Cide All Purpose Insecticide" is ready to market to cannabis cultivators nationally.
Research and grow medicinal cannabis for testing
With patient care in mind first, Med-X's cultivation lab conducts research and grows medicinal cannabis in various potencies for testing. We aim to ensure that cannabis grown for medical or recreational use is as safe as possible.
We innovate the everyday. The Med-X management team has built a cannabis company that focuses on ancillary products, research and development, and education.
Med-X is focusing on medical applications where real results are coming out of extensive research. Innovation begins with the doctors, scientists, and the experienced management team working together to bring products that impact people’s lives in positive ways.
As the legalization of medical and recreational cannabis continues to spread across the country, Med-X is prepared for the unprecedented, explosive growth of the industry by cultivating excellence across all three of its divisions.
The legalization of medical cannabis is taking over the United States. Oregon, Washington, and Colorado have seen massive tax gains from legalizing recreational use while California’s medical system continues to be a model for other states around the country. Soon, more than half of the states in the US will have some medical marijuana legislation.
Twenty-three states have made it legal, and it is pending in fourteen more.
As more states legalize medical and recreational cannabis, the demand for Med-X's quality products is growing. Innovation is where Med-X excels, and Med-X consumer-ready products support the expansion of the industry.
State by state, new requirements for contaminant testing and product potency are affecting cultivators who handle pests and molds with harmful and toxic treatments of the past. As laws remove harmful and poisonous pesticides from the cultivation facilities and require nontoxic treatments, Nature-Cide is positioned to become an industry standard for organic pest control management.
As the landscape of cannabis cultivation is changing, so is the landscape for equity crowdfunding. For the first time in history, everyone has the chance to own a piece of a startup company and we want you to join us on our amazing journey.
The cannabis industry has tremendous potential and our products are ready for cultivators who are looking to meet growing demand. With the hospitality and commercial pest control venues using and recommending Nature-Cide nationally, Med-X has created a perfect jump-off point into cannabis cultivation. Management's track record with product development coupled with multiple national distribution relationships presents the opportunity for success.
Now is a great time to consider investing in Med-X as we are positioned to embrace and benefit from the booming cannabis industry.
Ballots are heating up with cannabis laws, new businesses are sprouting up to provide products and supplies, and we believe we have the tools to capitalize on the massive growth of the cannabis industry. Make history with us and indicate your interest in Med-X as we take this industry by storm.
Thanks to the rapid growth of the cannabis industry, new trends have developed to better support this growth.
Multi-state licensing is crucial to national cannabis brands finding lasting success. States are beginning to require product potency and contaminant testing to ensure consumer safety, and new laboratories are emerging to meet these needs.
The landscape of cultivation is changing as licensed facilities grow in size and numbers to meet the booming medical and recreational demand for cannabis.
Cannabis cultivation materials, supplies, and medical research are deemed to grow into billion dollar industries on their own in a matter of years.
Our media magazine, The Marijuana Times, will draw advertisers and partners to this space in a market where many outlets block the promotion of cannabis related ads.
Our research and development of medical grade strains and potencies will play a long-term role in the business model and eventually distribute cannabis to the medical community.
Med-X is poised to dominate the market with one of the only tested and proven green alternative to pest control that will meet the new State licensing standards. Cultivation centers and growers will need a nontoxic solution, and that solution is Nature-Cide All Purpose Insecticide.
The industry is expanding. We have the right products, the right timing, and the right team in place to maximize our impact. We are first in the cannabis sector to bring this opportunity to the people.
Disrupting an industry, educating the public, and providing safe, effective patient care is our mission. We are working to make the world a better place through each and every division of our company. And that is why we are going to be a smart investment.
All Economic Value details, including future projections, employment numbers and or statistics, are sourced from The 2015 Marijuana Business Fact Book. Produced by the Marijuana Business Daily. Industry and revenue statistics are sourced from the 2014 ArcView Market Research Report.
What is Reg A+ Equity Crowdfunding?
In June 2015, the final Regulation A+ rules under Title IV of the JOBS Act of 2012 became effective, after approval by the Securities and Exchange Commission, paving the way for companies like Med-X, Inc. to raise up to $50 million from both accredited and non-accredited investors.
Med-X, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow cannabis for research and development purposes only.
THE SECURITIES OFFERED HEREBY ARE HIGHLY SPECULATIVE. INVESTING IN SHARES OF MED-X, INC. INVOLVES SIGNIFICANT RISKS. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND COULD BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES AND IF A PUBLIC MARKET DEVELOPS FOLLOWING THIS OFFERING IT MAY NOT CONTINUE.
MED-X, INC. 8236 REMMET AVENUE CANOGA PARK, CA 91304 - YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.
THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, MED-X, INC., ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO MED-X, INC.’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. MED-X, INC. DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.